Form 4: Entero Therapeutics CFO Sells Shares to Cover Tax Obligations

Sarah Romano, CFO of Entero Therapeutics, sold 476 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).

Summary

• On October 9, 2024, Sarah Romano, the Chief Financial Officer of Entero Therapeutics, Inc. (ENTO), sold 476 shares of the company's common stock.
• The sale was executed at a price of $0.446 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting and settlement of Restricted Stock Units (RSUs).
• The sale was mandated by Entero Therapeutics' policy to cover tax obligations through a 'sell to cover' transaction.
• Following the transaction, Romano still beneficially owns 18,014 shares, including unvested RSUs.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (sale of shares to cover taxes) and doesn't indicate any significant positive or negative sentiment. It's a neutral event.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction reflects a standard procedure for managing tax liabilities associated with equity compensation.

Key Dates

Keywords

Form 4, Entero Therapeutics, Sarah Romano, CFO, Stock Sale, Tax Withholding, RSUs, ENTO